Bazbiomedic Participates as GOLD Sponsor at the Korean Society for Laser Dermatology and Trichology Conference

Bazbiomedic, a company specializing in aesthetic medical devices, announced that it successfully participated as a GOLD sponsor at the '2025 Korean Society for Laser Dermatology and Trichology (KSLDT) 51st Autumn International Academic Conference,' held on December 14 at the Parnas Hotel in Seoul.

This academic conference, hosted by the Korean Society for Laser Dermatology and Trichology (President Park Minsu, Chief Director of Gangnam View Best Clinic), attracted approximately 4,300 domestic and international medical professionals and industry representatives, recording large-scale participation comparable to last year's autumn conference. This once again demonstrates the continued growth and influence of the KSLDT academic conference, with around 130 companies participating to showcase the latest aesthetic technologies and products.

As a GOLD sponsor, Bazbiomedic introduced new treatment strategies using its innovative medical device 'CUREjet,' demonstrating its potential to overcome the limitations of existing procedures. In a separate lecture hall, in-depth presentations were delivered to experts on the latest collagen regeneration technologies utilizing CUREjet.

Kim Hoon-young, Director of Pygmalion Clinic Cheongdam Branch, presented on the topic 'From Mechanical Signaling to Chemical Cues: Mechanisms that Awaken Fibroblasts,' introducing the core mechanisms of skin regeneration. Dr. Kim shared the latest research findings on how CUREjet's mechanical stimulation is converted into chemical signals that activate fibroblasts and induce collagen production, drawing significant interest from attendees.

Following this, Lee Yuseok, Director of Gangnam View Best Clinic, presented an innovative procedure under the theme 'A New Approach to Uniform Collagen Remodeling Using Liquid PCL with CUREjet.' Dr. Lee introduced a new treatment strategy that induces more natural and effective collagen regeneration by uniformly injecting liquid PCL (polycaprolactone) with CUREjet, suggesting the potential to overcome the limitations of conventional manual procedures.

A representative from Bazbiomedic stated, "Through this conference, we were able to strengthen our academic network with domestic and international medical professionals and present a new paradigm in aesthetic procedures with differentiated treatment strategies using CUREjet. We will continue our collaboration with the Korean Society for Laser Dermatology and Trichology, the largest academic society in Korea specializing in dermatological aesthetics, which has established itself as a platform for sharing the latest knowledge and clinical experience related to laser and energy-based devices (EBD). Through ongoing research, development, and academic activities, we will continue to prove the clinical value of CUREjet and contribute to the advancement of the aesthetic medical industry."